LONDON, Feb 5 (Reuters) - AstraZeneca and Oxford
University's COVID-19 vaccine has similar efficacy against the
"Kent" coronavirus variant currently circulating in Britain as
it does to the previously circulating variants, the university
said on Friday.
The findings, released in a preprint paper and not
peer-reviewed, also detailed recent analysis showing that
vaccination with the shot results in a reduction in the duration
of shedding and viral load, which may translate into a reduced
transmission of the disease, Oxford University said.
(Reporting by Alistair Smout; editing by Michael Holden)
Astrazeneca (AZN)
